Articles

• A novel formulation of selegiline for the treatment of Parkinson’s disease

  James W. Tetrud, William C. Koller

  • Full Text
• The comparative effects of medical therapies for Parkinson’s disease

  Stacy Horn, Matthew B. Stern

  • Full Text
• Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson’s disease

  Peter Jenner

  • Full Text
• Clinical trials of neuroprotection for Parkinson’s disease

  Peter A. LeWitt

  • Full Text
• A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson’s disease

  Moussa B.H. Youdim, Peter F. Riederer

  • Full Text